Pfizer Market Cap Surged by $26B After UK Authorized the Use of its COVID-19 Vaccine
Jastra Kranjec
December 8, 2020
0 Comments
The coronavirus pandemic put enormous pressure on the pharmaceutical industry, forcing pharma companies to roll out clinical trials for a COVID-19 vaccine at breakneck speed. Since the United Kingdom authorized the use of Pfizer and BioNTech’s COVID-19 vaccine, the US pharmaceutical giant has taken center stage in the COVID-19 fight. According to data presented by …
Read more
